Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions

Journal of Clinical Ultrasound

Volumn 31, Issue 5, 2003, Pages 227-238

  Kook, Shin Ho ^a   Kwag, Hyon Joo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast neoplasms; Contrast media; Diagnosis; Power Doppler ultrasonography; Ultrasonography

Indexed keywords

ECHO CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST LESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOMAMMOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MALE; MALIGNANT NEOPLASTIC DISEASE; MORPHOLOGY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BREAST DISEASES; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 0038587597     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcu.10172     Document Type: Article

References (18)

1. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1.
2. Kook SH, Park HW, Lee YR, et al. Evaluation of solid breast lesions with power Doppler sonography. J Clin Ultrasound 1999;27:231.
3. Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler US. Radiology 1997;203:164.
4. Cosgrove D. Tumor vascularity. Angiology 1996;47(suppl):55.
5. Birdwell RL, Ikeda DM, Jeffrey SS, et al. Preliminary experience with power Doppler imaging of solid breast masses. AJR Am J Roentgenol 1997;169:703.
6. Kedar RP, Cosgrove D, McCready R, et al. Microbubble contrast agent for color Doppler US: effects on breast masses. Radiology 1996;198:679.
7. Harvey CJ, Blomley MJK, Eckersley RJ, et al. Developments in ultrasound contrast media. Eur Radiol 2001;11:675.
8. Merritt CRB. Technology update. Radiol Clin North Am 2001;39:394.
9. Cosgrove D. Why do we need contrast agents for ultrasound? Clin Radiol 1996;51(suppl):1.
10. Huber S, Helbich T, Kettenbach J, et al. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US - early experience. Radiology 1998;208:485.
11. Moon WK, Im JG, Noh DY, et al. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent: initial experience. Radiology 2000;217:240.
12. Goldberg BB, Liu J, Burns PN, et al. Galactosebased intravenous sonographic contrast agents: experimental studies. J Ultrasound Med 1993;12:463.
13. Frouge C, Guinebretiere J, Contesso G, et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994;29:1043.
14. Schwarz KQ, Bezante GP, Chen X, et al. Quantitative echo contrast concentration measurement by Doppler sonography. Ultrasound Med Biol 1993;19:289.
15. Albrecht T, Urbank A, Mahler M, et al. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology 1998;207:339.
16. Blomley MJ, Albrecht T, Cosgrove DO, et al. Can relative contrast agent concentration be measured in vivo with color Doppler US? Radiology 1997;204:279.
17. Albrecht T, Patel N, Cosgrove DO, et al. Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: subjective and quantitative assessment. Acad Radiol 1998;5(suppl1):S195.
18. Schroeder RJ, Maeurer J, Hidajat N, et al. D-galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions. Invest Radiol 1999;34:109.